GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mad2 who wrote (1665)	11/27/1999 7:51:00 PM
From: Bo Didley	Read Replies (2) of 5582

Wall Street Journal is great for GUMM...!!!! It gives much exposure to the company, to one of its products,ZICAM, and to the web page: http://www.GUMMinvestors.com It also brings out the differences in the patent. QGLY patent stricly states its only for the ORAL mucosa, but Zicam is applied to the NASAL tissue. Every judge knows the difference between the mouth and nose. Something you learn when you're a kid and your parents say touch your ears, nose, mouth. The nose is very distinguishable from the mouth. The big difference between the two products is efficacy. Cold-eze costs a lot more per cold, tastes horrible, and only reduces the cold to about 6 days. On the other hand, ZICAM is cost efficient with enough gel to eliminate 3 separate colds, its soothing so even children like it, and it reduces the common cold to 1 1/2 days (second clinicals pending for confirmation to the scientists, but general users of the product have already conducted their own family tests and are sold on the product) I like the part where the Journal re-states the last news that ZICAM has 5 times the sales of the previous quarter. WoW ! bo

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next